A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Economic models buckle under strain of climate reality
Brazil’s All-Powerful Sugar Industry Is Souring the Country on EVs
When Can I Pre-Load Spider-Man 2?
Andrew Tate emphasizes power of brotherhood, asserts nothing can be achieved 'alone', fans say 'idea of Rambo is not real'
Clashes over fossil fuels, Gaza conflict cloud COP28 climate summit
Europe Faces an Inflation-Regime Reckoning Over Climate Goals
Geminids meteor shower began life in a ‘violent catastrophe’, scientists say
How Fortnite Players Can Get Their Share of the $245M In-App Purchase Settlement